Response to: 'Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony…but not Lockstep!'
Heart
.
2018 Dec;104(24):2077.
doi: 10.1136/heartjnl-2018-313851.
Authors
John Erwin Iii
1
2
,
Bernard Iung
3
Affiliations
1
Division of Cardiology/Department of Internal Medicine, Scott and White Medical Center Temple, Temple, Texas, USA.
2
Baylor Scott and White Health, Texas A&M University College of Medicine, Temple, Texas, USA.
3
Bichat Hospital, Paris, France.
PMID:
30482810
DOI:
10.1136/heartjnl-2018-313851
No abstract available
Keywords:
atrial fibrillation; cardiac procedures and therapy.
Publication types
Letter
Comment
MeSH terms
Anticoagulants
Atrial Fibrillation
Heart Valve Diseases*
Humans
Substances
Anticoagulants